Aquilo Capital Management

Aquilo Capital Management as of Dec. 31, 2020

Portfolio Holdings for Aquilo Capital Management

Aquilo Capital Management holds 17 positions in its portfolio as reported in the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spero Therapeutics (SPRO) 15.8 $76M 3.9M 19.39
Ishares Tr Nasdaq Biotech Put Option (IBB) 15.7 $76M 500k 151.42
Spdr Ser Tr S&p Biotech Put Option (XBI) 14.6 $70M 500k 140.81
Blueprint Medicines (BPMC) 8.9 $43M 380k 112.15
Ngm Biopharmaceuticals (NGM) 6.3 $31M 1.0M 30.30
Dicerna Pharmaceuticals 6.2 $30M 1.4M 22.03
Arrowhead Pharmaceuticals (ARWR) 5.8 $28M 366k 76.73
Anaptysbio Inc Common (ANAB) 5.4 $26M 1.2M 21.50
Uniqure Nv SHS (QURE) 5.3 $25M 702k 36.13
Regenxbio Inc equity us cm (RGNX) 4.7 $23M 503k 45.36
Magenta Therapeutics 3.7 $18M 2.3M 7.84
Amryt Pharma Sponsored Ads 2.4 $11M 800k 14.16
Pieris Pharmaceuticals (PIRS) 1.9 $9.2M 3.7M 2.50
Galapagos Nv Spon Adr (GLPG) 1.4 $6.9M 70k 98.99
Argenx Se Sponsored Adr (ARGX) 0.8 $3.7M 13k 294.09
Genmab A/s Sponsored Ads (GMAB) 0.8 $3.7M 90k 40.66
4d Molecular Therapeutics In (FDMT) 0.2 $829k 20k 41.45